NCT05972590 (FIFTY+) is a NA clinical trial of Biological samples collection (blood + feces) in Elderly Volunteers, sponsored by Bioaster.

Who is sponsoring NCT05972590?

NCT05972590 is sponsored by Bioaster.

What drugs are being tested in NCT05972590?

Interventions in NCT05972590: Biological samples collection (blood + feces).

What condition does NCT05972590 study?

NCT05972590 studies Elderly Volunteers.

Is NCT05972590 still recruiting?

NCT05972590 is currently completed. Last updated 19 March 2024.

Last reviewed 2024-03-19 · How we verify

NCT05972590: FIFTY+

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Characterization of Fecal Microbiota in a Population Aged 50 to 75 Years Targeted by Seasonal Vaccination

Completed NA Last updated 19 March 2024

What this trial tests

NA trial testing Biological samples collection (blood + feces) in Elderly Volunteers in 60 participants. Completed in 15 December 2023.

Timeline

25 July 2023

Primary endpoint
15 December 2023

15 December 2023

Quick facts

Lead sponsor	Bioaster
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	basic science
Enrollment	60
Start date	25 July 2023
Primary completion	15 December 2023
Estimated completion	15 December 2023
Sites	1 location across France

Drugs / interventions tested

Biological samples collection (blood + feces)

Conditions studied

Elderly Volunteers — all drugs for Elderly Volunteers →

Sponsor

Bioaster — full company profile →

Who can join

Adults 50 to 75, any sex, with Elderly Volunteers. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this interventional study is to constitute a biological samples collection collected from healthy elderly volunteers and used for scientific purposes. The main questions it aims to answer are: * Improving knowledge of the composition of the gut microbiota * Identify, isolate and culture microbiota species of interest in the field of health ageing or used as therapeutics associated to the vaccination * Determining the correlation between the gut microbiota composition and the immune response of individuals.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Bioaster trials

Trials by the same sponsor.

NCT06602388 — Human Internal BIOASTER's Samples Collection · not yet recruiting
NCT05701371 — BACTERIA ISOLATION FROM STOOLS COLLECTED FROM CENTENARIANS PEOPLE · terminated
NCT06862531 — A Single-center, Interventional Diagnostic Study With Minimal Risks and Constraints, Aimed at Longitudinally Evaluating · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05972590 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Bioaster
Last refreshed: 19 March 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05972590.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing